Submitted by comunicaciones on Fri, 09/05/2025 - 16:27
ECBE
ECBE PACIENTE INCONGRUENCIA DE GENERO
seccion ECBE
Referencias
Body
  1. Joseph A, Cliffe C, Hillyard M, Majeed A. Gender identity and the management of the transgender patient: a guide for non-specialists. J R Soc Med. abril de 2017;110(4):144-52.
  2. Beek TF, Cohen-Kettenis PT, Kreukels BPC. Gender incongruence/gender dysphoria and its classification history. Int Rev Psychiatry. 2016;28(1):5-12.
  3. Coleman E, Radix AE, Bouman WP, Brown GR, de Vries ALC, Deutsch MB, et al. Standards of Care for the Health of Transgender and Gender Diverse People, Version 8. Int J Transgend Health. 2022;23(Suppl 1):S1-259.
  4. Hembree WC, Cohen-Kettenis PT, Gooren L, Hannema SE, Meyer WJ, Murad MH, et al. Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 1 de noviembre de 2017;102(11):3869-903.
  5. UCSF Gender Affirming Health Program, Department of Family and Community Medicine, University of California San Francisco. Guidelines for the Primary and Gender-Affirming Care of Transgender and Gender Nonbinary People | Gender Affirming Health Program [Internet]. [citado 4 de julio de 2024]. Disponible en: https://transcare.ucsf.edu/guidelines.
  6. Robles García R, Ayuso-Mateos JL. CIE-11 and the depathologisation of the transgender condition. Rev Psiquiatr Salud Ment (Engl Ed). 2019;12(2):65-7.
  7. White Hughto JM, Reisner SL, Pachankis JE. Transgender stigma and health: A critical review of stigma determinants, mechanisms, and interventions. Soc Sci Med. diciembre de 2015;147:222-31.
  8. Safer JD, Coleman E, Feldman J, Garofalo R, Hembree W, Radix A, et al. Barriers to healthcare for transgender individuals. Curr Opin Endocrinol Diabetes Obes. abril de 2016;23(2):168-71.
  9. Goodman M, Adams N, Corneil T, Kreukels B, Motmans J, Coleman E. Size and Distribution of Transgender and Gender Nonconforming Populations: A Narrative Review. Endocrinol Metab Clin North Am. junio de 2019;48(2):303-21.
  10. Zucker KJ. Epidemiology of gender dysphoria and transgender identity. Sex Health. octubre de 2017;14(5):404-11.
  11. Zhang Q, Goodman M, Adams N, Corneil T, Hashemi L, Kreukels B, et al. Epidemiological considerations in transgender health: A systematic review with focus on higher quality data. Int J Transgend Health. 2020;21(2):125-37.
  12. Esteva de Antonio I, Gómez-Gil E, GIDSEEN Group. Coordination of healthcare for transsexual persons: a multidisciplinary approach. Curr Opin Endocrinol Diabetes Obes. diciembre de 2013;20(6):585-91.
  13. American Psychological Association. Guidelines for psychological practice with transgender and gender nonconforming people. Am Psychol. diciembre de 2015;70(9):832-64.
  14. Brouwers MC, Kerkvliet K, Spithoff K, AGREE Next Steps Consortium. The AGREE Reporting Checklist: a tool to improve reporting of clinical practice guidelines. BMJ. 8 de marzo de 2016;i1152.
  15. Whitlock BL, Duda ES, Elson MJ, Schwab PP, Uner OE, Wen S, et al. Primary Care in Transgender Persons. Endocrinol Metab Clin North Am. junio de 2019;48(2):377-90.
  16. American Psychiatric Association. Diagnostic and statistical manual of mental disorders (DSM-5 (R)). 5a ed. Arlington, TX, Estados Unidos de América: American Psychiatric Association Publishing; 2013.
  17. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, fifth edition, text revision (DSM-5-TR®): Test questions for the diagnostic criteria. Muskin PR, Dickerman AL, Drysdale A, Holderness CC, editores. Arlington, TX, Estados Unidos de América: American Psychiatric Association Publishing; 2023.
  18. CIE-11 para estadísticas de mortalidad y morbilidad [Internet]. [citado 25 de octubre de 2024]. Disponible en: https://icd.who.int/browse/2024-01/mms/es#411470068.
  19. Fleischman A, Russell M, Russell AN, Qi Y, Jewell V. Life Satisfaction and Gender Congruence in Transgender Individuals: A Role for Occupational Therapy. OTJR (Thorofare N J). 30 de julio de 2024;15394492241264467.
  20. Rodriguez-Wallberg K, Obedin-Maliver J, Taylor B, Van Mello N, Tilleman K, Nahata L. Reproductive health in transgender and gender diverse individuals: A narrative review to guide clinical care and international guidelines. Int J Transgend Health. 2023;24(1):7-25.
  21. Nadgauda AS, Butts S. Barriers to fertility preservation access in transgender and gender diverse adolescents: a narrative review. Ther Adv Reprod Health. 2024;18:26334941231222120.
  22. Corte constitucional de Colombia. Sentencia T-918/12. [Internet]. [citado 26 de julio de 2024]. Disponible en: https://www.corteconstitucional.gov.co/relatoria/2012/T-918-12.htm.
  23. Chiang T, Bachmann GA. The informed consent model is adequate for gender-affirming treatment: issues related with mental health assessment in the United States. J Sex Med. 27 de abril de 2023;20(5):584-7.
  24. Pérez López G. Gender identity: Current concepts and gender-affirming hormone therapy. Endocrinol Diabetes Nutr (Engl Ed). marzo de 2023;70 Suppl 1:27-37.
  25. Lombardo J, Simone N. Care of Transgender Persons. N Engl J Med. 9 de abril de 2020;382(15):1481.
  26. Shin SJ, Kumar A, Safer JD. Gender-Affirming Surgery: Perioperative Medical Care. Endocr Pract. abril de 2022;28(4):420-4.
  27. Diaz Tribaldos CD. Estándar clínico basado en la evidencia. Diagnóstico, tratamiento y seguimiento del paciente con obesidad. Hospital Universitario Nacional de Colombia. 26 de enero de 2022 [citado 5 de julio de 2024]; Disponible en: https://repositorio.unal.edu.co/handle/unal/81019
  28. Jiang DD, Gallagher S, Burchill L, Berli J, Dugi D. Implementation of a Pelvic Floor Physical Therapy Program for Transgender Women Undergoing Gender-Affirming Vaginoplasty. Obstet Gynecol. mayo de 2019;133(5):1003-11.
  29. Narayan SK, Morrison T, Dugi DD, Mosser S, Berli JU. Gender Confirmation Surgery for the Endocrinologist. Endocrinol Metab Clin North Am. junio de 2019;48(2):403-20.
  30. Yeung H, Kahn B, Ly BC, Tangpricha V. Dermatologic Conditions in Transgender Populations. Endocrinol Metab Clin North Am. junio de 2019;48(2):429-40.
  31. Oodit R, Biccard BM, Panieri E, Alvarez AO, Sioson MRS, Maswime S, et al. Guidelines for Perioperative Care in Elective Abdominal and Pelvic Surgery at Primary and Secondary Hospitals in Low-Middle-Income Countries (LMIC’s): Enhanced Recovery After Surgery (ERAS) Society Recommendation. World J Surg. agosto de 2022;46(8):1826-43.
  32. Bedar M, Dejam D, Caprini RM, Huang KX, Cronin BJ, Khetpal S, et al. An enhanced recovery after surgery protocol for facial feminization surgery reduces perioperative opioid usage, pain, and hospital stay. J Plast Reconstr Aesthet Surg. octubre de 2023;85:393-400.
  33. Altman AD, Robert M, Armbrust R, Fawcett WJ, Nihira M, Jones CN, et al. Guidelines for vulvar and vaginal surgery: Enhanced Recovery After Surgery Society recommendations. Am J Obstet Gynecol. octubre de 2020;223(4):475-85.
  34. Tirrell AR, Abu El Hawa AA, Bekeny JC, Fan KL, Del Corral G. Minimizing opioid consumption by eliminating patient-controlled analgesia after penile inversion vaginoplasty with enhanced recovery after surgery (ERAS) protocol. Andrology. febrero de 2022;10(2):232-40.
  35. Ospino-Rodriguez GE, et al. Estándar clínico basado en la evidencia: prevención y tratamiento del dolor agudo postoperatorio del paciente adulto en el Hospital Universitario Nacional de Colombia. 12 de julio de 2024 [citado 1 de noviembre de 2024]; Disponible en: https://www.hun.edu.co/sites/default/files/2024-10/Daruma_vfinal_DAP_1.pdf.
  36. Melendez-Rhenals S, et al. Estándar clínico basado en la evidencia: diagnóstico y tratamiento del paciente adulto con infección de piel y tejidos blandos en el Hospital Universitario Nacional de Colombia. 13 de marzo de 2024 [citado 1 de noviembre de 2024]; Disponible en: https://www.hun.edu.co/sites/default/files/2024-04/02_24_Compilado_IPTB_Daruma_final.pdf.
  37. Cortés JA, et al. Estándar Clínico Basado en la Evidencia: Diagnóstico y tratamiento del paciente con infección de vías urinarias complicada en el Hospital Universitario Nacional de Colombia. 28 de septiembre de 2022 [citado 1 de noviembre de 2024]; Disponible en: https://www.hun.edu.co/sites/default/files/2022-10/IVU.pdf.
  38. Sayegh F, Ludwig DC, Ascha M, Vyas K, Shakir A, Kwong JW, et al. Facial Masculinization Surgery and its Role in the Treatment of Gender Dysphoria. J Craniofac Surg. julio de 2019;30(5):1339-46.
  39. Steffenssen MCW, Kristiansen ALH, Damsgaard TE. A Systematic Review and Meta-analysis of Functional Shoulder Impairment After Latissimus Dorsi Breast Reconstruction. Ann Plast Surg. enero de 2019;82(1):116-27.
  40. Rosen HN, Hamnvik OPR, Jaisamrarn U, Malabanan AO, Safer JD, Tangpricha V, et al. Bone Densitometry in Transgender and Gender Non-Conforming (TGNC) Individuals: 2019 ISCD Official Position. J Clin Densitom. 2019;22(4):544-53.
  41. US Preventive Services Task Force, Nicholson WK, Silverstein M, Wong JB, Barry MJ, Chelmow D, et al. Screening for Breast Cancer: US Preventive Services Task Force Recommendation Statement. JAMA. 11 de junio de 2024;331(22):1918-30.
  42. WHO. WHO Position Paper on Mammography Screening [Internet]. Geneva: World Health Organization; 2014 [citado 4 de julio de 2024]. (WHO Guidelines Approved by the Guidelines Review Committee). Disponible en: http://www.ncbi.nlm.nih.gov/books/NBK269545/
  43. Peña Torres E. Guía de práctica clínica (GPC) para la detección temprana, tratamiento integral, seguimiento y rehabilitación del cáncer de mama: Versión para profesionales de la salud. 2013 [citado 5 de julio de 2024]; Disponible en: https://www.medicosgeneralescolombianos.com/images/Guias_2013/gpc_19prof_sal_camama.pdf
  44. Whitton K, Baber R. Androgen-based therapies in women. Best Pract Res Clin Endocrinol Metab. enero de 2024;38(1):101783.
  45. Stier EA, Clarke MA, Deshmukh AA, Wentzensen N, Liu Y, Poynten IM, et al. International Anal Neoplasia Society’s consensus guidelines for anal cancer screening. Int J Cancer. 15 de mayo de 2024;154(10):1694-702.
  46. Ilott I, Rick J, Patterson M, Turgoose C, Lacey A. What is protocol-based care? A concept analysis. J Nurs Manag. octubre de 2006;14(7):544-52.
  47. Gulwani S. Programming by examples: applications, algorithms, and ambiguity resolution. En: Proceedings of the 19th International Symposium on Principles and Practice of Declarative Programming [Internet]. Namur Belgium: ACM; 2017 [citado 4 de julio de 2024]. p. 2-2. Disponible en: https://dl.acm.org/doi/10.1145/3131851.3131853
  48. Klein DA, Paradise SL, Goodwin ET. Caring for Transgender and Gender-Diverse Persons: What Clinicians Should Know. Am Fam Physician. 1 de diciembre de 2018;98(11):645-53.
  49. Griffin G. A Dictionary of Gender Studies. En Oxford University Press; 2017 [citado 4 de julio de 2024]. Disponible en: https://www.oxfordreference.com/display/10.1093/acref/9780191834837.001.0001/acref-9780191834837
  50. National LGBTQIA+ health education center. LGBTQIA+ Glossary of Terms for Health Care Teams [Internet]. LGBTQIA+. [citado 4 de julio de 2024]. Disponible en: https://www.lgbtqiahealtheducation.org/publication/glossary/
  51. Jun GT, Ward J, Morris Z, Clarkson J. Health care process modelling: which method when? Int J Qual Health Care. junio de 2009;21(3):214-24.
  52. Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 29 de marzo de 2021;372:n71.
  53. Morales Arreola F. Gestación subrogada y filiación: su regulación en Tabasco y Sinaloa. 2019 [citado 31 de octubre de 2024]; Disponible en: http://repositorio-digital.cide.edu//handle/11651/3685